SEC Filings | Tempest Therapeutics

Filing date	Description	Form	View
Mar 01, 2018	Notice of Exempt Offering of Securities	D	0001533635-18-000003.pdf 0001533635-18-000003.rtf View HTML
May 11, 2022		D	0001209191-22-028252.pdf 0001209191-22-028252.rtf 0001209191-22-028252.xls View HTML
Feb 27, 2019	Notice of Exempt Offering of Securities - amendment	D/A	0001533635-19-000001.pdf 0001533635-19-000001.rtf View HTML
Feb 12, 2020	Notice of Exempt Offering of Securities - amendment	D/A	0001533635-20-000001.pdf 0001533635-20-000001.rtf View HTML
May 02, 2022	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001193125-22-136738.pdf 0001193125-22-136738.rtf 0001193125-22-136738.xls View HTML
May 01, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001193125-23-130398.pdf 0001193125-23-130398.rtf 0001193125-23-130398.xls View HTML
May 02, 2022	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-22-136754.pdf 0001193125-22-136754.rtf View HTML
May 09, 2022	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-22-144331.pdf 0001193125-22-144331.rtf 0001193125-22-144331.xls View HTML
May 09, 2022	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-22-144339.pdf 0001193125-22-144339.rtf View HTML
May 26, 2022	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-22-160984.pdf 0001193125-22-160984.rtf 0001193125-22-160984.xls View HTML

Data provided by Kaleidoscope.